FDA Inspection 1245923 — Probi USA Inc.
The FDA completed an inspection of Probi USA Inc. on July 30, 2024 in Lafayette, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 30, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Lafayette, CO (United States)